CN113234233A - Europium-based metal-organic framework material with antibiotic fluorescence recognition function and preparation method thereof - Google Patents

Europium-based metal-organic framework material with antibiotic fluorescence recognition function and preparation method thereof Download PDF

Info

Publication number
CN113234233A
CN113234233A CN202110607233.8A CN202110607233A CN113234233A CN 113234233 A CN113234233 A CN 113234233A CN 202110607233 A CN202110607233 A CN 202110607233A CN 113234233 A CN113234233 A CN 113234233A
Authority
CN
China
Prior art keywords
europium
organic framework
based metal
framework material
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202110607233.8A
Other languages
Chinese (zh)
Other versions
CN113234233B (en
Inventor
邹吉勇
李玲
游胜勇
章力
谌开红
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Applied Chemistry Jiangxi Academy of Sciences
Original Assignee
Institute of Applied Chemistry Jiangxi Academy of Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Applied Chemistry Jiangxi Academy of Sciences filed Critical Institute of Applied Chemistry Jiangxi Academy of Sciences
Priority to CN202110607233.8A priority Critical patent/CN113234233B/en
Publication of CN113234233A publication Critical patent/CN113234233A/en
Application granted granted Critical
Publication of CN113234233B publication Critical patent/CN113234233B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G83/00—Macromolecular compounds not provided for in groups C08G2/00 - C08G81/00
    • C08G83/008—Supramolecular polymers
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • G01N21/643—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" non-biological material
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/18—Metal complexes
    • C09K2211/188—Metal complexes of other metals not provided for in one of the previous groups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • G01N2021/6432—Quenching

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)

Abstract

A europium-based metal-organic framework material with antibiotic fluorescence recognition and a preparation method thereof are disclosed, wherein 2, 5-furandicarboxylic acid is taken as a ligand, rare earth europium ions are taken as a metal center, and the europium-based metal-organic framework material is synthesized by a solvothermal method. The material prepared by the invention has the advantages of simple preparation method, high purity, good activity, no need of pretreatment on the material, easy implementation, and quick, simple and convenient detection of antibiotics, good selectivity, high sensitivity, low detection limit, cyclic regeneration and the like, and can be used for detection after being dried at room temperature, so that the material has great potential application value in the preparation of fluorescent probe solid-state devices and the detection of antibiotics.

Description

Europium-based metal-organic framework material with antibiotic fluorescence recognition function and preparation method thereof
Technical Field
The invention relates to a europium-based metal-organic framework material with antibiotic fluorescence recognition and a preparation method thereof, belonging to the technical field of porous molecular crystal materials.
Background
Since 1929, the british scholars alexander fleming discovered penicillin first and applied it clinically, antibiotics as a kind of drugs for the treatment of bacterial infection diseases, has the advantages of broad antibacterial spectrum, definite therapeutic effect, easy use, many varieties, large output, low price, etc., and is widely used for the treatment of bacterial infections in human and animals. However, with the widespread use of antibiotics, the problem of antibiotic abuse is becoming more and more prominent. Antibiotic abuse can cause a range of physical and environmental problems, such as excessive use of antibiotics can cause serious drug resistance in humans and animals, and antibiotic residues are also discharged into the environment through metabolic action, which can cause serious environmental pollution. Therefore, there is a need to develop and develop a method for detecting antibiotics efficiently and rapidly. Methods for detecting antibiotic pollutants, which are developed at present, include polarography, supercritical fluid chromatography high performance liquid chromatography, gas chromatography, spectroscopic analysis, electrochemical methods and the like, however, the methods generally have the problems of time consumption, high cost, complicated pretreatment, requirement of professionals and the like, and the application of the methods is severely restricted. Therefore, it is necessary to develop a method for quantitatively detecting the antibiotic rapidly at low cost without pretreatment.
The metal-organic framework fluorescent sensing material is considered to be one of the most promising detection methods and is widely used for identifying harmful substances such as anions, cations, small molecular organic substances and the like, see H. -C. Z H o u et al, Chem. Soc. Rev., 2014, 43, 5415-. The method allows the presence of an analyte to be detected simply by the change in fluorescence intensity as a function of analyte concentration. Compared with the traditional analysis technology, the fluorescence sensing detection based on the metal-organic framework has the characteristics of high precision, high sensitivity, small size, short response time, good adaptability and the like. In recent years, many reports have been made on the fluorescent response of a metal-organic framework to a single type of antibiotic, for example, Zhou et al have reported a metal-organic framework material of terbium and zinc, and the results of fluorescent sensing detection studies show that: the material has good detection performance on nitrofurans such as furazolidone, furacilin, nitrofurantoin and the like in water (see: Z. -H. Z. h.o u and the like, Inorg. Chem. 2018, 57, 3833); han et al have reported a sodium and europium metal organic framework material, and the results of fluorescence sensing detection research show that: the material has good selective detection capability on ornidazole and the like in water (see: M. -L. Han et al, J. Mater. Chem. C, 2017, 5, 8469).
Publication No. CN110128674 discloses a water-stable rare earth metal organic framework material for fluorescence detection of sulfonamides antibiotics and a preparation method thereof, however, research on simultaneous fluorescence response of various antibiotics is still less, and particularly, the simultaneous fluorescence response of the rare earth metal-organic framework to various antibiotics is not reported.
Disclosure of Invention
The invention aims to solve the problems and obtain a europium-based metal-organic framework material which has chemical stability and simultaneously responds to nitrofuran antibiotics, nitroimidazole antibiotics and sulfonamide antibiotics in a fluorescence manner.
The technical scheme of the invention is that the europium-based metal-organic framework material with antibiotic fluorescence recognition has a chemical formula as follows: { [ Eu ]2(FDA)3 (H2O)3(DMF)·DMF·2H2O]} n (ii) a In the formula: n is a natural number from 1 to positive infinity; FDA2-Is obtained by deprotonating 2, 5-furandicarboxylic acid; DMF is N, N-dimethylformamide.
The europium-based metal-organic framework material belongs to a monoclinic system, and the space group isP21 /nThe unit cell parameters are: a = 10.3176(3) A, b = 21.0431(7) A, c = 15.6348(4) A,α= 90°，ß= 93.844(3) °，γ= 90 °。
the basic structural unit of the europium-based metal-organic framework material contains two kinds of europium ions with coordination environment and 3 deprotonated ligands FDA2-3 pieces of the mixtureWater molecule, 1 coordinated DMF molecule and 1 free DMF molecule and 2 free water molecules; EuO with europium ion adopting deformed single-cap square antiprism9Coordination mode, Eu1 ions with ligands from 6 dehydrogenation ligands FDA, respectively2-8 oxygen atoms in (a) and oxygen atoms from 1 water are coordinated; eu2 ions with the respective of 4 dehydrogenating ligands from FDA2-6 oxygen atoms in the group, 2 oxygen atoms in water and 1 DMF; adjacent europium ions pass through dehydrogenation ligand FDA2-A three-dimensional network structure is formed in space.
The europium-based metal-organic framework material can be simplified into a single node of 6,6 connectionpcuTopology with dot symbol {412.63}。
A preparation method of europium-based metal-organic framework material with antibiotic fluorescence recognition comprises the following synthetic steps:
(1) respectively reacting organic ligands H2Dissolving FDA into N, N-dimethylformamide solvent;
(2) adding Mn (OAc)2 .4H2O and Eu (NO)3)3 .6H2Dissolving O in water;
(3) mixing the two solutions obtained in the steps (1) and (2), then putting the mixture into a closed hydrothermal reaction kettle, reacting for 72 hours at a constant temperature of 90 ℃, taking out a product, and separating a solid;
(4) the solid was washed with N, N-dimethylformamide several times to obtain colorless bulk crystals.
Said H2The concentration of the N, N-dimethylformamide solution of FDA is 0.01-1 mol/L; the Mn (OAc)2 .4H2The concentration of the water solution of O is 0.01-1 mol/L; the Eu (NO)3)3 .6H2The concentration of the O aqueous solution is 0.01-1 mol/L.
The europium-based metal-organic framework material can stably exist in water, methanol, ethanol, N, N-dimethylformamide, N, N-dimethylacetamide, tetrahydrofuran, acetonitrile, 1, 4-dioxane and glycol solvents.
The europium-based metal-organic framework material generates a fluorescence enhancement effect in methanol, N, N-dimethylformamide and N, N-dimethylacetamide.
The europium-based metal-organic framework material can detect nitrofuran antibiotics such as Furazolidone (FZD), Nitrofurantoin (NFT) and Nitrofurazone (NFZ), nitroimidazole antibiotics such as Metronidazole (MND), ornidazole (RND), 1, 2-methyl-5-nitroimidazole (DND) and Ornidazole (OND) and sulfanilamide antibiotics such as Sulfadiazine (SDZ) and Sulfadimidine (SMZ) through fluorescence change.
The europium-based metal-organic framework material is at a low concentration (0-16 [ mu ] mol. L)-1) The fluorescence change curve in the antibiotic DMF solution is in a linear relationship with the antibiotic concentration, and the detection limit is 0.185 mu mol.L-1，0.173µmol·L-1，0.141µmol·L-1，0.346µmol·L-1，0.378µmol·L-1，0.255µmol·L-1，0.323µmol·L-1，0.148µmol·L-1，0.139µmol·L-1The europium-based metal-organic framework material can be applied to the field of antibiotic detection fluorescent probes.
The europium-based metal-organic framework material has the beneficial effects that the europium-based metal-organic framework material is different from the existing europium-based framework material and is a new material; the europium-based metal-organic framework material has a linear relation between a fluorescence change curve and the concentration of antibiotics under the condition of a low-concentration DMF solution; different from the prior art, the test conditions are aqueous solutions; in addition, the prior art can only singly recognize the sulfonamide antibiotics through fluorescence, the invention can simultaneously and effectively recognize the three antibiotics, and the detection limit is much lower than that of the prior art.
The material prepared by the invention has the advantages of simple preparation method, high purity, good activity, no need of pretreatment on the material, easy implementation, and quick, simple and convenient detection of antibiotics, good selectivity, high sensitivity, low detection limit, cyclic regeneration and the like, and can be used for detection after being dried at room temperature, so that the material has great potential application value in the preparation of fluorescent probe solid-state devices and the detection of antibiotics.
Drawings
FIG. 1 is a three-dimensional structure diagram of a europium-based metal-organic framework material of the present invention;
FIG. 2 shows fluorescence spectra of europium-based metal-organic frameworks of the present invention in different solvents;
FIG. 3 is a fluorescence spectrum of different concentrations of FZD solutions for europium-based metal-organic frameworks in an example of the present invention;
FIG. 4 is the FZD concentration versus fluorescence intensity I of the rare earth metal organic framework material in the examples of the present invention0Graph of/I, inset is the FZD concentration versus the fluorescence intensity I of the rare earth metal organic framework material in the examples0Stern-Volmer Linear plot of/I ([ FZD)]≤16μmol/L)；
FIG. 5 is a fluorescence spectrum of different concentrations of NFT solutions with europium-based metal-organic frameworks according to an embodiment of the present invention;
FIG. 6 is the fluorescence intensity I of the rare earth metal organic framework material in the NFT concentration vs. example of the invention0Graph of/I, inset is the concentration of NFT versus the fluorescence intensity I of the rare earth metal organic framework material in the examples0Stern-Volmer Linear plot of/I ([ NFT)]≤16μmol/L)；
FIG. 7 is a fluorescence spectrum of different concentrations of NFZ solutions with europium-based metal-organic frameworks according to an embodiment of the present invention;
FIG. 8 is the fluorescence intensity I of the rare earth metal organic framework material in the example of NFZ concentration vs. the fluorescence intensity of the rare earth metal organic framework material of the present invention0Graph of/I, inset is the concentration of NFZ versus the fluorescence intensity I of the rare earth metal organic framework material in the examples0Stern-Volmer Linear plot of/I ([ NFZ)]≤16μmol/L)；
FIG. 9 is a fluorescence spectrum of europium-based metal-organic framework materials in different concentrations of MND solutions according to an embodiment of the present invention;
FIG. 10 shows fluorescence intensity I of a rare-earth metal organic framework material in an example of MND concentration vs. concentration of the rare-earth metal organic framework material according to the invention0Graph of MND concentration versus fluorescence intensity I of the rare earth metal organic framework material in the examples0Stern-Volmer Linear plot of/I ([ MND)]≤16μmol/L)；
FIG. 11 is a fluorescence spectrum of different concentrations of RND solutions with europium-based metal-organic frameworks according to an embodiment of the present invention;
FIG. 12 shows the RND concentration versus fluorescence intensity I of the rare earth metal organic framework material in the example of the present invention0Graph of RND concentration versus fluorescence intensity I of the rare earth metal organic framework material in the examples0Stern-Volmer Linear plot ([ RND) of/I]≤16μmol/L)；
FIG. 13 is a fluorescence spectrum of different concentrations of DND solutions with europium-based metal-organic frameworks in an example of the present invention;
FIG. 14 shows the fluorescence intensity I of the rare-earth metal organic framework material in the example of DND concentration vs. the invention0Graph of DND concentration versus fluorescence intensity I of the rare earth metal organic framework material in the examples0Stern-Volmer Linear plot of/I ([ DND)]≤16μmol/L)；
FIG. 15 is a fluorescence spectrum of europium-based metal-organic framework materials in different concentrations of OND solutions according to an embodiment of the present invention;
FIG. 16 is the OND concentration versus fluorescence intensity I of the rare earth metal organic framework material in the examples of the present invention0The plot of the OND concentration versus the fluorescence intensity I of the rare earth metal organic framework material in the examples0Stern-Volmer Linear plot ([ OND)/I]≤16μmol/L)；
FIG. 17 is a fluorescence spectrum of different concentrations of SDZ with europium-based metal-organic frameworks in an example of the present invention;
FIG. 18 shows the concentration of SDZ versus the fluorescence intensity I of the rare earth metal organic framework material in the example of the present invention0Graph of SDZ concentration versus fluorescence intensity I of the rare earth metal organic framework material in the examples0Stern-Volmer Linear plot of/I ([ SDZ)]≤16μmol/L)；
FIG. 19 is a fluorescence spectrum of different concentrations of SMD solutions with europium-based metal-organic frameworks in an example of the present invention;
FIG. 20 shows fluorescence intensity I of rare earth metal organic frameworks in an example of SMD concentration vs. concentration according to the invention0Graph of SMD concentration versus fluorescence intensity I of the rare earth metal organic framework material in the examples0Stern-Volmer Linear plot of/I ([ SMD]≤16μmol/L)。
Detailed Description
This embodiment is a kind of device havingThe europium-based metal-organic framework material for the fluorescent recognition of antibiotics has the chemical formula: { [ Eu ]2(FDA)3 (H2O)3(DMF)·DMF·2H2O]} n 。
In the formula: n is a natural number from 1 to positive infinity; FDA2-Is obtained by deprotonating 2, 5-furandicarboxylic acid; DMF is N, N-dimethylformamide.
The europium-based metal-organic framework material belongs to a monoclinic system, and the space group isP21 /nThe unit cell parameters are: a = 10.3176(3) A, b = 21.0431(7) A, c = 15.6348(4) A,α= 90°，ß= 93.844(3) °，γ= 90 °。
the basic structural unit of the europium-based metal-organic framework material contains two kinds of europium ions with coordination environment and 3 deprotonated ligands FDA 2-3 coordinated water molecules, 1 coordinated DMF molecule and 1 free DMF molecule and 2 free water molecules; EuO with europium ion adopting deformed single-cap square antiprism9Coordination mode, Eu1 ions with ligands from 6 dehydrogenation ligands FDA, respectively2-8 oxygen atoms in (a) and oxygen atoms from 1 water are coordinated; eu2 ions with the respective of 4 dehydrogenating ligands from FDA 2-6 oxygen atoms in the group, 2 oxygen atoms in water and 1 DMF; adjacent europium ions pass through dehydrogenation ligand FDA2-A three-dimensional network structure is formed in space.
The europium-based metal-organic framework material can be simplified into a single node of 6,6 connectionpcuTopology with dot symbol {412.63}。
The preparation method of the europium-based metal-organic framework material with antibiotic fluorescence recognition of the embodiment comprises the following synthetic steps:
(1) 31.2 mg of H2FDA was dissolved in 3mL of N, N-dimethylformamide solvent.
(2) 24.5mg of Mn (OAc)2 .4H2O and 44.6mgEu (NO3) 3 .6H2O was dissolved in 3mL of water.
(3) Mixing the two solutions in the steps 1 and 2, then putting the mixture into a closed hydrothermal reaction kettle, reacting for 72 hours at a constant temperature of 90 ℃, taking out a product, and separating a solid.
(4) The solid was washed 3 times with N, N-dimethylformamide and water to give colorless bulk crystals with a yield of 65% calculated on the basis of europium metal.
The properties of the europium-based metal-organic framework material with antibiotic fluorescence recognition prepared in the example are characterized as follows:
(1) the structure of europium-based metal-organic framework material with antibiotic fluorescence recognition of this example was determined:
the crystal structure is measured by using a Supernova type X-ray single crystal diffractometer, using Mo-Kalpha rays (lambda = 0.71073A) subjected to graphite monochromatization as an incident radiation source, collecting diffraction points in an omega-phi scanning mode, correcting by a least square method to obtain unit cell parameters, solving a difference Fourier electron density diagram by using a SHELXL-97 direct method to obtain a crystal structure, and correcting by Lorentz and a polarization effect. All H atoms were synthesized by difference Fourier and determined by ideal position calculations. The exact number of solvent molecules was determined by thermogravimetric and elemental analysis tests, and the detailed crystal determination data is shown in table 1.
Figure DEST_PATH_IMAGE001
FIG. 1 is a three-dimensional structural diagram of the europium-based metal-organic framework material of this example, wherein n is a natural number from 1 to positive infinity, indicating that the material is a polymer.
(2) The fluorescence property of the europium-based metal-organic framework material of the embodiment is characterized:
FIG. 2 shows fluorescence spectra of europium-based metal-organic frameworks in different solvents according to the present invention. The figure shows that: the europium-based metal-organic framework material has a fluorescence enhancement effect in methanol, N, N-dimethylformamide and N, N-dimethylacetamide. And other solvents have little influence on the fluorescence intensity of the europium-based metal-organic framework material.
FIG. 3 is a fluorescence spectrum of different concentrations of FZD solutions for europium-based metal-organic frameworks in the examples of the present invention. As can be seen from the figure: when the FZD is gradually added into the DMF solution of the europium-based metal-organic framework material, the fluorescence intensity of the FZD shows a descending trend along with the increase of the amount of the FZD, the change is obvious, and finally fluorescence quenching occurs, which indicates that the europium-based metal-organic framework material has good fluorescence response to the FZD and can be used as an FZD fluorescent probe.
FIG. 4 shows FZD concentration versus fluorescence intensity I of europium-based metal-organic framework materials in examples of the present invention0Plot of/I, inset is FZD concentration versus fluorescence intensity I of europium-based metal-organic framework materials in the examples0Stern-Volmer Linear plot of/I ([ FZD)]Less than or equal to 16 mu mol/L). As can be seen from the figure: at a lower FZD concentration (0-16 mu mol/L), the europium-based metal-organic framework material has a fluorescence intensity I0the/I and the FZD concentration are in a linear relation, and the detection limit is 0.185 mu mol.L-1When the concentration of FZD is higher, the fluorescence intensity I of the europium-based metal-organic framework material0the/I shows a slow-first and fast-second trend along with the concentration of the FZD and does not show a linear relation any more.
FIG. 5 is a fluorescence spectrum of different concentrations of NFT solutions with europium-based metal-organic frameworks according to an embodiment of the present invention. As can be seen from the figure: when NFT is gradually added into DMF solution of europium-based metal-organic framework material, the fluorescence intensity of the europium-based metal-organic framework material shows a descending trend along with the increase of the amount of the NFT, the change is obvious, and fluorescence quenching is finally generated, which shows that the europium-based metal-organic framework material has good fluorescence response to the NFT and can be used as an NFT fluorescent probe.
FIG. 6 shows the NFT concentration versus fluorescence intensity I of europium-based metal-organic frameworks in examples of the present invention0Graph of/I inset is the NFT concentration versus the europium-based metal-organic framework material fluorescence intensity I in the examples0Stern-Volmer Linear plot of/I ([ NFT)]Less than or equal to 16 mu mol/L). As can be seen from the figure: when the NFT concentration is lower (0-16 mu mol/L), the europium-based metal-organic framework material has the fluorescence intensity I0the/I and the NFT concentration are in a linear relation, and the detection limit is 0.173 mu mol.L-1Europium-based metal-organic framework material fluorescence intensity I at higher NFT concentration0the/I shows a slow-first and fast-second trend with NFT concentration, no longer in a linear relationship.
FIG. 7 shows the fluorescence spectra of different concentrations of NFZ solutions with europium-based metal-organic frameworks according to the example of the present invention. As can be seen from the figure: when the NFZ is gradually added into the DMF solution of the europium-based metal-organic framework material, the fluorescence intensity of the europium-based metal-organic framework material shows a descending trend along with the increase of the amount of the NFZ, the change is obvious, and finally fluorescence quenching occurs, which shows that the europium-based metal-organic framework material has good fluorescence response to the NFZ and can be used as an NFZ fluorescent probe.
FIG. 8 shows the NFZ concentration versus fluorescence intensity I of europium-based metal-organic frameworks in examples of the present invention0Graph of/I inset is the NFZ concentration versus the fluorescence intensity I of the europium-based metal-organic framework materials in the examples0Stern-Volmer Linear plot of/I ([ NFZ)]Less than or equal to 16 mu mol/L). As can be seen from the figure: at a lower NFZ concentration (0-16. mu. mol/L), the europium-based metal-organic framework material has a fluorescence intensity I0the/I and the NFZ concentration are in a linear relation, and the detection limit is 0.141 mu mol.L-1The europium-based metal-organic framework material has fluorescence intensity I at higher NFZ concentration0the/I shows a slow-first and fast-second trend with the NFZ concentration, no longer in a linear relationship.
FIG. 9 shows the fluorescence spectra of europium-based metal-organic frameworks in different concentrations of MND solutions according to the example of the present invention. As can be seen from the figure: when MND is gradually added into a DMF solution of the europium-based metal-organic framework material, the fluorescence intensity of the europium-based metal-organic framework material shows a descending trend along with the increase of the quantity of the MND, the change is obvious, and finally fluorescence quenching occurs, so that the europium-based metal-organic framework material has good fluorescence response to the MND and can be used as a MND fluorescent probe.
FIG. 10 shows the fluorescence intensity I of europium-based metal-organic framework materials in the MND concentration versus example of the invention0Plot of the concentration of MND versus the fluorescence intensity I of the europium-based metal-organic framework materials in the examples0Stern-Volmer Linear plot of/I ([ MND)]Less than or equal to 16 mu mol/L). As can be seen from the figure: at low MND concentration (0-16 mu mol/L), the europium-based metal-organic framework material has fluorescence intensity I0the/I and the MND concentration are in a linear relation, and the detection limit is 0.346 mu mol.L-1At MND concentrationHigh time, europium-based metal-organic framework material fluorescence intensity I0the/I shows a slow-first and fast-second trend with the MND concentration and no longer shows a linear relationship.
FIG. 11 shows the fluorescence spectra of different concentrations of RND solutions with europium-based metal-organic frameworks according to the example of the present invention. As can be seen from the figure: when the RND is gradually added into the DMF solution of the europium-based metal-organic framework material, the fluorescence intensity of the europium-based metal-organic framework material shows a descending trend along with the increase of the quantity of the RND, the change is obvious, and finally fluorescence quenching occurs, which shows that the europium-based metal-organic framework material has good fluorescence response to the RND and can be used as an RND fluorescent probe.
FIG. 12 shows the RND concentration versus fluorescence intensity I of europium-based metal-organic framework materials in examples of the present invention0Graph of/I with inset graph of RND concentration versus fluorescence intensity I of europium-based metal-organic framework materials in the examples0Stern-Volmer Linear plot ([ RND) of/I]Less than or equal to 16 mu mol/L). As can be seen from the figure: at a low RND concentration (0-16. mu. mol/L), the europium-based metal-organic framework material has a fluorescence intensity I0the/I and the RND concentration are in a linear relation, and the detection limit is 0.378 mu mol.L-1Europium-based metal-organic framework material fluorescence intensity I at higher RND concentration0the/I shows a slow-first and fast-second trend with RND concentration, no longer linear.
FIG. 13 shows the fluorescence spectra of different concentrations of DND solutions with europium-based metal-organic frameworks in the examples of the present invention. As can be seen from the figure: when DND is gradually added into the DMF solution of the europium-based metal-organic framework material, the fluorescence intensity of the europium-based metal-organic framework material shows a descending trend along with the increase of the amount of DND, the change is obvious, and finally fluorescence quenching occurs, which shows that the europium-based metal-organic framework material has good fluorescence response to DND and can be used as a DND fluorescent probe.
FIG. 14 shows the fluorescence intensity I of europium-based metal-organic framework materials in examples of DND concentration according to the invention0Plot of the DND concentration versus the fluorescence intensity I of the europium-based metal-organic framework materials in the examples0Stern-Volmer Linear plot of/I ([ DND)]Less than or equal to 16 mu mol/L). As can be seen from the figure: at lower DND concentrations (0-16. mu. mol/L), europium-based goldFluorescence intensity of metal-organic framework material I0The concentration of the DND is in a linear relation, and the detection limit is 0.255 mu mol.L-1Europium-based metal-organic framework material fluorescence intensity I at higher DND concentration0the/I shows a slow-first followed by fast trend with DND concentration, no longer linear.
FIG. 15 shows the fluorescence spectra of europium-based metal-organic frameworks in different concentrations of OND solutions according to the example of the present invention. As can be seen from the figure: when OND is gradually added into a DMF solution of the europium-based metal-organic framework material, the fluorescence intensity of the OND shows a descending trend along with the increase of the amount of the OND, the change is obvious, and fluorescence quenching is finally generated, so that the europium-based metal-organic framework material has good fluorescence response to the OND and can be used as an OND fluorescent probe.
FIG. 16 shows the OND concentration versus fluorescence intensity I of europium-based metal-organic framework materials in examples of the present invention0Plot of the OND concentration versus the fluorescence intensity I of the europium-based metal-organic framework materials in the examples0Stern-Volmer Linear plot ([ OND)/I]Less than or equal to 16 mu mol/L). As can be seen from the figure: when the OND concentration is lower (0-16 mu mol/L), the europium-based metal-organic framework material has the fluorescence intensity I0the/I and the OND concentration are in a linear relation, and the detection limit is 0.323 mu mol.L-1Europium-based metal-organic framework material fluorescence intensity I at higher OND concentration0the/I shows a slow-first and fast-second trend with the OND concentration and no longer shows a linear relationship.
FIG. 17 is a fluorescence spectrum of different concentrations of SDZ solutions with europium-based metal-organic frameworks in an example of the present invention. As can be seen from the figure: when SDZ is gradually added into a DMF solution of the europium-based metal-organic framework material, the fluorescence intensity of the europium-based metal-organic framework material shows a descending trend along with the increase of the amount of the SDZ, the change is obvious, and finally fluorescence quenching occurs, which shows that the europium-based metal-organic framework material has good fluorescence response to the SDZ and can be used as an SDZ fluorescent probe.
FIG. 18 shows the SDZ concentration versus fluorescence intensity I of europium-based metal-organic framework materials in examples of the present invention0Graph of/I inset shows SDZ concentration versus fluorescence intensity of europium-based metal-organic framework materials in the examplesDegree I0Stern-Volmer Linear plot of/I ([ SDZ)]Less than or equal to 16 mu mol/L). As can be seen from the figure: at a lower SDZ concentration (0-16. mu. mol/L), the europium-based metal-organic framework material has a fluorescence intensity I0the/I and the SDZ concentration are in a linear relation, and the detection limit is 0.148 mu mol.L-1The europium-based metal-organic framework material has a fluorescence intensity I at a higher SDZ concentration0the/I shows a slow-first and fast-second trend with the SDZ concentration and no longer shows a linear relationship.
FIG. 19 is a fluorescence spectrum of different concentrations of SMZ solutions with europium-based metal-organic frameworks in an example of the present invention. As can be seen from the figure: when SMZ is gradually added into a DMF solution of the europium-based metal-organic framework material, the fluorescence intensity of the europium-based metal-organic framework material shows a descending trend along with the increase of the amount of the SMZ, the change is obvious, and fluorescence quenching finally occurs, which indicates that the europium-based metal-organic framework material has good fluorescence response to the SMZ and can be used as an SMZ fluorescent probe.
FIG. 20 shows the SMZ concentration versus fluorescence intensity I of europium-based metal-organic framework materials in examples of the invention0Plot of the SMZ concentration versus the fluorescence intensity I of the europium-based metal-organic framework materials in the examples0Stern-Volmer Linear plot of/I ([ SMZ)]Less than or equal to 16 mu mol/L). As can be seen from the figure: at low SMZ concentration (0-16 mu mol/L), the europium-based metal-organic framework material has fluorescence intensity I0the/I and the SMZ concentration are in a linear relation, and the detection limit is 0.139 mu mol.L-1The europium-based metal-organic framework material has fluorescence intensity I at higher SMZ concentration0the/I shows a slow-first and fast-second trend with SMZ concentration and no longer shows a linear relationship.

Claims (7)

1. A europium-based metal-organic framework material with antibiotic fluorescence recognition is characterized in that: the europium-based metal-organic framework material has the chemical formula: { [ Eu ]2(FDA)3 (H2O)3(DMF)·DMF·2H2O]} n ；
In the formula: n is a natural number from 1 to positive infinity; FDA2-Is obtained by deprotonating 2, 5-furandicarboxylic acid; DMF is N, N-dimethylformamide;
the europium-based metal-organic framework material belongs to a monoclinic system, and the space group isP21 /nThe unit cell parameters are: a = 10.3176(3) A, b = 21.0431(7) A, c = 15.6348(4) A,α= 90°，ß= 93.844(3) °，γ= 90 °；
the basic structural unit of the europium-based metal-organic framework material contains two kinds of europium ions with coordination environment and 3 deprotonated ligands FDA2-3 coordinated water molecules, 1 coordinated DMF molecule and 1 free DMF molecule and 2 free water molecules; EuO with europium ion adopting deformed single-cap square antiprism9Coordination mode, Eu1 ions with ligands from 6 dehydrogenation ligands FDA, respectively2-8 oxygen atoms in (a) and oxygen atoms from 1 water are coordinated; eu2 ions with the respective of 4 dehydrogenating ligands from FDA2-6 oxygen atoms in the group, 2 oxygen atoms in water and 1 DMF; adjacent europium ions pass through dehydrogenation ligand FDA2-Forming a three-dimensional network structure in space;
the europium-based metal-organic framework material can be simplified into a single node of 6,6 connectionpcuTopology with dot symbol {412.63}。
2. The europium-based metal-organic framework material with antibiotic fluorescence recognition function of claim 1, wherein the europium-based metal-organic framework material is stable in water, methanol, ethanol, N, N-dimethylformamide, N, N-dimethylacetamide, tetrahydrofuran, acetonitrile, 1, 4-dioxane and ethylene glycol solvents; the europium-based metal-organic framework material generates a fluorescence enhancement effect in methanol, N, N-dimethylformamide and N, N-dimethylacetamide.
3. The europium-based metal-organic framework material with antibiotic fluorescence recognition function of claim 1, wherein the europium-based metal-organic framework material is used for detecting nitrofuran antibiotics of furazolidone, nitrofurantoin and nitrofuracilin and nitroimidazole antibiotics of metronidazole, ornidazole, 1, 2-methyl-5-nitroimidazole and ornidazole by fluorescence change.
4. The europium-based metal-organic framework material with antibiotic fluorescence recognition function of claim 3, wherein the fluorescence change curve of the europium-based metal-organic framework material in a low-concentration antibiotic DMF solution is in a linear relationship with the antibiotic concentration, and the detection limit of the europium-based metal-organic framework material is 0.185 μmol-L-1，0.173µmol·L-1，0.141µmol·L-1，0.346µmol·L-1，0.378µmol·L-1，0.255µmol·L-1，0.323µmol·L-1(ii) a The europium-based metal-organic framework material can be applied to the field of antibiotic detection fluorescent probes.
5. The europium-based metal-organic framework material with antibiotic fluorescent recognition function of claim 4, wherein the low concentration is 0-16 μmol-L-1。
6. A preparation method of europium-based metal-organic framework material with antibiotic fluorescence recognition is characterized by comprising the following synthesis steps:
(1) respectively reacting organic ligands H2Dissolving FDA into N, N-dimethylformamide solvent;
(2) adding Mn (OAc)2 .4H2O and Eu (NO)3)3 .6H2Dissolving O in water;
(3) mixing the two solutions obtained in the steps (1) and (2), then putting the mixture into a closed hydrothermal reaction kettle, reacting for 72 hours at a constant temperature of 90 ℃, taking out a product, and separating a solid;
(4) and washing the solid for multiple times by using N, N-dimethylformamide to obtain the colorless blocky crystal europium-based metal-organic framework material with antibiotic fluorescence recognition.
7. The method for preparing europium-based metal-organic framework material with antibiotic fluorescent recognition according to claim 6,characterized in that H is2The concentration of the N, N-dimethylformamide solution of FDA is 0.01-1 mol/L; the Mn (OAc)2 .4H2The concentration of the water solution of O is 0.01-1 mol/L; the Eu (NO)3)3 .6H2The concentration of the O aqueous solution is 0.01-1 mol/L.
CN202110607233.8A 2021-06-01 2021-06-01 Europium-based metal-organic framework material with antibiotic fluorescence recognition function and preparation method thereof Active CN113234233B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110607233.8A CN113234233B (en) 2021-06-01 2021-06-01 Europium-based metal-organic framework material with antibiotic fluorescence recognition function and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110607233.8A CN113234233B (en) 2021-06-01 2021-06-01 Europium-based metal-organic framework material with antibiotic fluorescence recognition function and preparation method thereof

Publications (2)

Publication Number Publication Date
CN113234233A true CN113234233A (en) 2021-08-10
CN113234233B CN113234233B (en) 2022-10-25

Family

ID=77136104

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110607233.8A Active CN113234233B (en) 2021-06-01 2021-06-01 Europium-based metal-organic framework material with antibiotic fluorescence recognition function and preparation method thereof

Country Status (1)

Country Link
CN (1) CN113234233B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115304783A (en) * 2022-08-27 2022-11-08 吉林大学 Room-temperature preparation method and application of fluorescent Eu-MOG material
CN117065730A (en) * 2023-08-03 2023-11-17 中国电建集团重庆工程有限公司 New material for removing or detecting tetracycline in liquid and detection system thereof
CN117343346A (en) * 2023-12-04 2024-01-05 内蒙古大学 Ultrasensitive europium-based MOFs sensor for visually identifying clenbuterol hydrochloride, and preparation method and application thereof

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007254723A (en) * 2006-02-23 2007-10-04 Fujifilm Corp Eu-CONTAINING INORGANIC COMPOUND, LUMINESCENT COMPOSITION CONTAINING THE SAME AND ILLUMINANT, SOLID-STATE LASER APPARATUS AND LIGHT EMITTING DEVICE
CN102757453A (en) * 2012-07-16 2012-10-31 南开大学 Multifunctional rare earth metal-organic framework and preparation method thereof
CN105567218A (en) * 2015-12-25 2016-05-11 哈尔滨工业大学 Red luminescent material europium coordination polymer and preparation method thereof and preparation method of complex light energy conversion film based on red luminescent material europium coordination polymer
CN106674534A (en) * 2016-12-16 2017-05-17 南开大学 Europium rare earth metal-organic frame material and preparation method and application thereof
CN106916317A (en) * 2017-02-27 2017-07-04 三峡大学 A kind of Rare Earth Europium base organic crystalline material, prepares and the application on fluorescence identifying antibiotic
CN108998007A (en) * 2018-08-02 2018-12-14 江西省科学院应用化学研究所 A kind of preparation method of rare earth metal organic framework materials
CN110003251A (en) * 2019-04-29 2019-07-12 江西省科学院应用化学研究所 A kind of preparation and application of double fluorescence response europium base molecule crystalline materials
CN110128674A (en) * 2019-05-31 2019-08-16 聊城大学 It is a kind of for fluorescence detection sulfa antibiotics, the rare earth metal organic framework materials that water is stable and preparation method thereof
CN111829996A (en) * 2020-06-23 2020-10-27 江苏大学 Preparation method of lanthanide metal organic framework test strip for visually detecting tetracycline antibiotics
CN112029111A (en) * 2020-09-18 2020-12-04 三峡大学 Preparation method of novel luminescent Eu-based organic framework material for antibiotic identification

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007254723A (en) * 2006-02-23 2007-10-04 Fujifilm Corp Eu-CONTAINING INORGANIC COMPOUND, LUMINESCENT COMPOSITION CONTAINING THE SAME AND ILLUMINANT, SOLID-STATE LASER APPARATUS AND LIGHT EMITTING DEVICE
CN102757453A (en) * 2012-07-16 2012-10-31 南开大学 Multifunctional rare earth metal-organic framework and preparation method thereof
CN105567218A (en) * 2015-12-25 2016-05-11 哈尔滨工业大学 Red luminescent material europium coordination polymer and preparation method thereof and preparation method of complex light energy conversion film based on red luminescent material europium coordination polymer
CN106674534A (en) * 2016-12-16 2017-05-17 南开大学 Europium rare earth metal-organic frame material and preparation method and application thereof
CN106916317A (en) * 2017-02-27 2017-07-04 三峡大学 A kind of Rare Earth Europium base organic crystalline material, prepares and the application on fluorescence identifying antibiotic
CN108998007A (en) * 2018-08-02 2018-12-14 江西省科学院应用化学研究所 A kind of preparation method of rare earth metal organic framework materials
CN110003251A (en) * 2019-04-29 2019-07-12 江西省科学院应用化学研究所 A kind of preparation and application of double fluorescence response europium base molecule crystalline materials
CN110128674A (en) * 2019-05-31 2019-08-16 聊城大学 It is a kind of for fluorescence detection sulfa antibiotics, the rare earth metal organic framework materials that water is stable and preparation method thereof
CN111829996A (en) * 2020-06-23 2020-10-27 江苏大学 Preparation method of lanthanide metal organic framework test strip for visually detecting tetracycline antibiotics
CN112029111A (en) * 2020-09-18 2020-12-04 三峡大学 Preparation method of novel luminescent Eu-based organic framework material for antibiotic identification

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
SEBASTIAANAKERBOOM等: "Crystal structure and luminescence of complexes of Eu(III) and Tb(III) with furan-2,5-dicarboxylate", 《INORGANICA CHIMICA ACTA》 *
方蓉等: "稀土铕有机配合物的研究进展及其应用", 《包装工程》 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115304783A (en) * 2022-08-27 2022-11-08 吉林大学 Room-temperature preparation method and application of fluorescent Eu-MOG material
CN115304783B (en) * 2022-08-27 2023-07-25 吉林大学 Room temperature preparation method and application of fluorescent Eu-MOG material
CN117065730A (en) * 2023-08-03 2023-11-17 中国电建集团重庆工程有限公司 New material for removing or detecting tetracycline in liquid and detection system thereof
CN117343346A (en) * 2023-12-04 2024-01-05 内蒙古大学 Ultrasensitive europium-based MOFs sensor for visually identifying clenbuterol hydrochloride, and preparation method and application thereof
CN117343346B (en) * 2023-12-04 2024-03-08 内蒙古大学 Ultrasensitive europium-based MOFs sensor for visually identifying clenbuterol hydrochloride, and preparation method and application thereof

Also Published As

Publication number Publication date
CN113234233B (en) 2022-10-25

Similar Documents

Publication Publication Date Title
CN113234233B (en) Europium-based metal-organic framework material with antibiotic fluorescence recognition function and preparation method thereof
CN110128674B (en) Water-stable rare earth metal organic framework material for fluorescence detection of sulfonamide antibiotics and preparation method thereof
CN108998007B (en) Preparation method of rare earth metal organic framework material
CN107556305B (en) Fluorescent probe for detecting aluminum ions, preparation method and application
CN107245334B (en) A kind of water soluble polymer fluoresceins fluorescence probe and preparation method thereof detecting mercury ion
CN108559096B (en) Luminescent metal organic framework material for detecting antibiotic pollutants in water
CN111943907B (en) Fluorescent probe capable of simultaneously detecting TNT and TNP and preparation method thereof
CN112029496B (en) Fluorescent array sensor for distinguishing and detecting metal ions and preparation method thereof
CN107417671B (en) Coumarin derivative containing quinoline substitution, preparation method thereof and application of coumarin derivative on ratio type pH fluorescent probe
CN107421932A (en) Utilize the method for nitrogen phosphorus doping carbon quantum dot probe in detecting Cr VI
CN107987282B (en) Water-stable lanthanide metal-organic framework material, preparation and application thereof
CN106589400B (en) A kind of application of sulfydryl silver cluster coordination polymer in oxygen detection
Su et al. A Cd (II)-based MOF as a dual-responsive luminescent probe for highly selective detection of Fe3+ cation and nitrofurantoin
CN114133581B (en) Mg-MOFs, preparation method thereof and application thereof in iron ion detection
CN108587607A (en) The luminescent metal organic framework material and its preparation method and application detected for Thiocyanate ion in water
CN101735798A (en) Rare earth organic framework material having sensing function to acetone, preparation method and application thereof
CN108384027B (en) Zinc-organic framework with acetylacetone fluorescent response and preparation method thereof
NL2030557B1 (en) Europium—based metal-organic framework material for fluorescence recognition of antibiotics and preparation method thereof
CN110669500B (en) Preparation of terbium-based rare earth crystalline material and application of terbium-based rare earth crystalline material in fluorescence detection of antibiotics in water
CN116082654B (en) Cadmium metal coordination polymer, preparation method thereof and application of cadmium metal coordination polymer in detection of metronidazole
CN112940279B (en) Layered column type zinc-based metal-organic framework material and preparation method thereof
CN109852377B (en) Seven-core Ln-Ba cluster crystalline material and preparation method and application thereof
CN109181683B (en) Calcium-metal-based organic framework material and preparation method and application thereof
CN106977392A (en) For detecting ascorbic rare earth organic framework materials and preparation method thereof
CN110818616B (en) Fluorescent probe for identifying thiocyanate radical and preparation method and detection method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant